Amakuru ashimishije aherutse kugaragara mu Kigo gishinzwe Isuzuma ry’Imiti (CDE) cy’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa: igeragezwa rya KSD-101 Injection, ryakozwe na Hensen Bio, ryemejwe. Ikoreshwa ryagaragajwe ni iry’ “Ibibyimba by’amaraso bifitanye isano na EBV bitarakira uburyo busanzwe bwo kuvura.”
Ubu buvuzi bushya burimo kuboneka ku barwayi bujuje ibisabwa ku isi yose binyuze mu ishami mpuzamahanga ry’ibitaro bya oncology bya Beijing Region South.**. Twiyemeje guhindura ubushakashatsi bwa siyansi bugezweho mu buvuzi, dutanga serivisi z’ubuvuzi zo ku rwego rwo hejuru ku barwayi mpuzamahanga ndetse n’uburyo bushya bwo kuvura.
KSD-101 ni urukingo rw’uturemangingo tw’umubiri, rukomoka kuri monocytes z’abantu kandi rurimo udukoko twa antigens twa kanseri dufitanye isano na EBV. Ibyavuye mu igeragezwa ryayo rya Phase I byagaragajwe mu nama ngarukamwaka ya 2025 y’ishyirahamwe ry’abahanga mu by’amaraso mu Burayi (EHA), bigaragaza ubushobozi bwayo bukomeye mu bijyanye no kuvura indwara z’umubiri.
Inyigo y’ikizamini cya Phase I yigaga ku barwayi bafite ubwoko butandukanye bw’indwara ziterwa na virusi ya Epstein-Barr (EBV-LPD), harimo indwara nyinshi ziterwa no kutagira icyo zikora nka Angioimmunoblastic T-cell Lymphoma (AITL), izuru/peripheral NK/T-cell Lymphoma (ENKTL), indwara ya virusi ya Epstein-Barr iterwa na virusi itera SIDA idakira (CAEBV), EBV-associated Hemophagocytic Lymphohistiocytosis (HLH), Diffuse Large B-cell Lymphoma (DLBCL), na Hodgkin Lymphoma (HL).
Ibisubizo by’ubushakashatsi byagaragaje ko mu gihe cy’ibyumweru 42.7, kuvurwa hakoreshejwe KSD-101 byatumye indwara igabanuka, abarwayi benshi bakaba barabonye kandi bagakomeza kumererwa neza. Aya makuru atanga icyizere gishya ku barwayi bananiwe ubuvuzi busanzwe.
Ku bijyanye n'umutekano, ingaruka mbi zijyanye n'ubuvuzi (AEs) zari izoroheje cyane, nko kugira ingaruka ku ntera, umuriro, na lymphadenopathy. Nta burozi bwagaragaye ku rwego rwa ≥3, bigaragaza ko umuntu ashobora kwihanganira indwara. Ibi bigaragaza ko KSD-101 idakora neza gusa ahubwo ko ifite umutekano mu rugero runaka, ishyigikira ubushobozi bwayo bwo kuvura igihe kirekire.
**Kuki wahitamo Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo ka Beijing?**
Nk'ahantu hizewe ho kuvura abarwayi mpuzamahanga, dutanga serivisi zuzuye kandi zivuga indimi nyinshi z'ubuvuzi mpuzamahanga. Kuva ku isuzuma rya mbere no guhindura gahunda yo kuvura kugeza ku ikurikiranwa, itsinda ryacu ry'impuguke ryiyemeje gutanga ubuvuzi bwihariye kandi bunoze kuri buri murwayi mpuzamahanga.
Ntureke ngo imipaka y'uturere ikubuze kubona ubuvuzi bwiza bushoboka. Niba wowe cyangwa umwe mu bagize umuryango wawe arwaye ibibyimba by'amaraso bifitanye isano na EBV kandi akaba atarakira ubuvuzi busanzwe, twandikire vuba.
**Twandikire ubu kugira ngo urebe uko gahunda yo kuvura ikorwa**
Itsinda ryacu ry’Ishami Mpuzamahanga ryiteguye kugufasha. Ushobora kutuvugisha ukoresheje uburyo ubu bukurikira kugira ngo utangire urugendo rwawe rugana ku buvuzi buhanitse:
- ���� Gutanga inama kuri telefoni: 400-880-3716
- ��� Ubujyanama kuri WeChat: 17801183037
- ��� Imeri:
- 100085_010@163.com
- myimmnet@163.com
**Ishami Mpuzamahanga ry'Ibitaro bya Oncology byo mu Karere k'Amajyepfo muri Beijing**
Idirishya ryawe Mpuzamahanga ryo Kuvura Kanseri
Igihe cyo kohereza ubutumwa: Werurwe-12-2026